Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Mechanisms for Laser-Induced Rejuvenation

NCT: NCT06489301 · RECRUITING

NCT IDNCT06489301
StatusRECRUITING
Start Date2025-07-16
Completion2028-12

Brief Summary

It has shown that laser wounding of geriatric skin protects it against skin cancer. The purpose of this study is to determine the origin of cells called fibroblasts which are present after treatment with Fractionated Laser Resurfacing (FLR). These cells restore a youth-like ultraviolet B (UVB) response, but where they come from is currently unknown. The study recruits subjects who are scheduled to undergo abdominoplasties to investigate the origin of those cells stimulated by laser treatment.

Frequently Asked Questions

What is Mechanisms for Laser-Induced Rejuvenation?

Mechanisms for Laser-Induced Rejuvenation is a clinical trial registered under NCT06489301. Current status: RECRUITING.

What is the status of NCT06489301?

The current status of NCT06489301 (Mechanisms for Laser-Induced Rejuvenation) is: RECRUITING.

When did Mechanisms for Laser-Induced Rejuvenation start?

Mechanisms for Laser-Induced Rejuvenation started on 2025-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.